MP
EHC icon

Mangrove Partners’s Encompass Health EHC Stock Holding History

Mangrove Partners’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$560K Buy
5,537
+945
+21% +$97.9K 0.04% 196
2026
Q1 		$444K Buy
+4,592
New +$471K 0.04% 217
2022
Q1 		– Sell
-251,397
Closed -$13.1M – 462
2021
Q4 		$13.1M Buy
+251,397
New +$13M 0.78% 18

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Mangrove Partners's EHC Position: Q2 2026 in Review

Mangrove Partners increased its Encompass Health (EHC) stake by 21% in Q2 2026, buying an estimated $97.9K and bringing the position to 5,537 shares worth $560K. The position accounts for 0.04% of the portfolio, ranked #196.

Mangrove Partners first reported a position in EHC in Q4 2021 and has held it in 3 quarters since. The position peaked at $13.1M in Q4 2021. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Mangrove Partners held 5,537 shares of Encompass Health worth $560K as of Q2 2026.
  • Mangrove Partners bought 945 Encompass Health shares in Q2 2026, an estimated $97.9K.
  • Encompass Health made up 0.04% of Mangrove Partners's portfolio in Q2 2026, its #196 holding.
  • Mangrove Partners first reported a position in Encompass Health in Q4 2021 and has held it in 3 quarters since.
  • Mangrove Partners's Encompass Health position peaked at $13.1M in Q4 2021.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Mangrove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.